Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
V Gurewich, … , R L Suddith, R Greenlee
V Gurewich, … , R L Suddith, R Greenlee
Published June 1, 1984
Citation Information: J Clin Invest. 1984;73(6):1731-1739. https://doi.org/10.1172/JCI111381.
View: Text | PDF
Research Article Article has an altmetric score of 3

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.

  • Text
  • PDF
Abstract

A single-chain 55,000-mol wt form of urokinase (UK), similar to that previously isolated from urine, was purified from a transformed kidney cell culture medium and characterized; and its fibrinolytic properties were evaluated. The preparation immunoprecipitated with UK antiserum, had a low intrinsic amidolytic activity that was 0.1% of its active derivative, and resisted diisopropyl fluorophosphate treatment and inactivation by plasma inhibitors. The single-chain UK was therefore designated pro-UK. In the presence of plasmin and during clot lysis, activation by conversion to two-chain, 55,000-mol wt UK (TC-UK) was demonstrated. This did not occur during blood clotting nor on incubation with purified thrombin. Clot lysis in plasma consistently occurred in 2-5 h with 50-100 IU per ml of pro-UK, whereas comparable lysis was inconsistently achieved by 500-1,000 IU of UK. Pro-UK, in sharp contrast to UK, caused no fibrinogen degradation at fibrinolytic concentrations. In the absence of a clot, pro-UK in plasma was stable for more than 2 d. When a clot was added after incubation (37 degrees C) for 50 h, activation to full lytic activity took place. The findings in vivo were comparable but the rapid clearance of pro-UK required that it be given by a constant infusion despite its plasma stability. In rabbits, a UK-resistant species, pro-UK was significantly (P less than 0.001) more efficacious than TC-UK but neither induced significant fibrinogen degradation. In dogs, a more sensitive species, the high specificity of thrombolysis by pro-UK contrasted with the defibrinogenation and uncontrollable bleeding that accompanied thrombolysis by UK. It was concluded that clot lysis by pro-UK is more effective and specific than UK. The advantage of pro-UK is in the limitation of its activation to the site of a clot. This can be explained by an activation mechanism that is dependent, under physiological conditions, on fibrin-stabilized plasmin.

Authors

V Gurewich, R Pannell, S Louie, P Kelley, R L Suddith, R Greenlee

×

Total citations by year

Year: 2023 2021 2020 2019 2017 2016 2013 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1969 1962 1953 Total
Citations: 1 1 1 3 1 1 1 3 2 3 1 3 1 2 2 1 4 4 7 3 5 4 8 11 10 9 11 14 17 21 27 22 21 11 3 1 1 1 1 243
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (243)

Title and authors Publication Year
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role.
Singh R, Gautam P, Sharma C, Osmolovskiy A
2023
The ANXA2/S100A10 Complex—Regulation of the Oncogenic Plasminogen Receptor
AG Bharadwaj, E Kempster, DM Waisman
Biomolecules 2021
Peripheral Nerve Tissue Engineering and Regeneration
J Phillips, D Hercher, T Hausner
2020
Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia
S Kaviarasi, E Yuba, A Harada, UM Krishnan
Journal of Controlled Release 2019
Thrombolysis with rhPro-UK 3 to 6 hours after embolic stroke in rat
CH Hao, WX Ding, Q Sun, XX Li, WT Wang, ZY Zhao, LD Tang
Neurological Research 2019
Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown
V Gurewich
Cardiovascular Drugs and Therapy 2019
Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke
C Hao, W Ding, X Xu, Q Sun, X Li, W Wang, Z Zhao, L Tang
Biomedical Reports 2017
Trauma Induced Coagulopathy
E Gonzalez, HB Moore, EE Moore
2016
Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy
S Absar, K Nahar, YM Kwon, F Ahsan
Pharmaceutical Research 2013
Mutant Prourokinase with Adjunctive C1-Inhibitor Is an Effective and Safer Alternative to tPA in Rat Stroke
S Tomasi, P Sarmientos, G Giorda, V Gurewich, A Vercelli, C Kleinschnitz
PloS one 2011
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Medium optimization and immobilization of purified fibrinolytic URAK from Bacillus cereus NK1 on PHB nanoparticles
V Deepak, S Ilangovan, MV Sampathkumar, MJ Victoria, SP Pasha, SB Pandian, S Gurunathan
Enzyme and microbial technology 2010
Rutherford's Vascular Surgery
HA Liebman, IC Weitz
Rutherford's Vascular Surgery 2010
New insights into the molecular mechanisms of the fibrinolytic system
DC Rijken, HR Lijnen
Journal of Thrombosis and Haemostasis 2009
The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator
JY Kim, JK Kim, JS Park, Y Byun, CK Kim
Biomaterials 2009
Effect of Recombinant Single-Chain Urokinase-Type Plasminogen Activator on Experimental Pulmonary Embolism
Y Wang, C Wang, Y Yang, B Pang
Clinical and Applied Thrombosis/Hemostasis 2009
Fundamental and Clinical Cardiology Series
PD Stein
Cardiovascular Disease in the Elderly 2008
Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis
AV Iakhiaev, A Nalian, K Koenig, S Idell
Thrombosis Research 2007
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes
2007
Synthesis, Characterization, and in Vitro Activity of Dendrimer−Streptokinase Conjugates
X Wang, R Inapagolla, S Kannan, M Lieh-Lai, RM Kannan
Bioconjugate Chemistry 2007
The Vascular Endothelium II
S Moncada, A Higgs
2006
Molecular mechanisms of fibrinolysis
G Cesarman-Maus, KA Hajjar
British Journal of Haematology 2005
Fibrin(ogen)olytic character of FIIaisolated from Agkistrodon acutus venom
Y WANG, X LIANG, J CHEN, Q CHEN, P QIU, X LIN, G YAN
Acta Pharmacologica Sinica 2005
Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase
CE Hagemeyer, I Tomic, U Weirich, J Graeber, T Nordt, MS Runge, C Bode, K Peter
Journal of Thrombosis and Haemostasis 2004
Complementary and Alternative Approaches to Biomedicine
EL Cooper, N Yamaguchi
2004
Catheter-directed Thrombolytic Therapy for Limb Ischemia: Current Status and Controversies
MK Razavi, DS Lee, LV Hofmann
Journal of Vascular and Interventional Radiology 2003
Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis
JN Liu, JX Liu, BL Bf, Z Sun, JL Zuo, PZ Px, J Zhang, YC Yh, V Gurewich
Circulation research 2002
Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation
Z Sun, PX Zhang, P Wang, V Gurewich, HY Shen, JN Liu
Thrombosis Research 2002
Plasminogen activator inhibitor-1 and the kidney
AA Eddy
American journal of physiology. Renal physiology 2002
Notfallbehandlung des akuten Koronarsyndroms
HR Arntz, DC Gulba, U Tebbe
2002
High-level expression and characterization of single chain urokinase-type plasminogen activator (scu-PA) produced in recombinant Chinese hamster ovary (CHO) cells
JS Kim, MK Min, EC Jo
Biotechnology and Bioprocess Engineering 2001
Elements of the Fibrinolytic System
H Lijnen
Annals of the New York Academy of Sciences 2001
Fibrinolytics and Antifibrinolytics
F Bachmann
2001
Recombinant Protein Drugs
P Buckel
2001
Kirk-Othmer Encyclopedia of Chemical Technology
GR Lenz, HG Schoepke, TC SPAULDING
Kirk-Othmer Encyclopedia of Chemical Technology 2000
Fibrinolysis: an unfinished agenda
V Gurewich
Blood Coagulation and Fibrinolysis 2000
Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells
P Wang, J Zhang, Z Sun, Y Chen, V Gurewich, J Liu
Thrombosis Research 2000
Recent developments in thrombolytic therapy
D Collen, HR Lijnen
Fibrinolysis and Proteolysis 2000
Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences
S Ghosh, SM Ellerbroek, Y Wu, MS Stack
Fibrinolysis and Proteolysis 2000
Coronary Circulation and Myocardial Ischemia
MR Pinsky, A Artigas, JF Dhainaut
2000
Molecular basis of thrombolytic therapy
H Lijnen, D Collen
Journal of Nuclear Cardiology 2000
Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction
M Moser, C Bode
Expert Opinion on Investigational Drugs 1999
Management of Acute Coronary Syndromes
CP Cannon
1999
Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: comparison of infusion, single-bolus, and split-bolus administration
H R Michels, J J Hoffman, F W Bär
Journal of Thrombosis and Thrombolysis 1999
Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow
N Mcwilliam, L Robbie, N Booth, B Bennett
British Journal of Haematology 1998
CLINICAL APPLICATIONS OF THROMBOLYTIC THERAPY FOR ARTERIAL AND GRAFT OCCLUSION
MD Malone, L Barber, AJ Comerota
Surgical Clinics of North America 1998
Thrombolytic agents — an updated overview
DC Gulba, C Bode, MS Runge, K Huber
Fibrinolysis and Proteolysis 1998
Plasma clearance of urokinase-type plasminogen activator
ME der Kaaden, DC Rijken, TJ Berkel, J Kuiper
Fibrinolysis and Proteolysis 1998
Herz-Kreislauf-Erkrankungen
D Ganten, K Ruckpaul
1998
Thrombolytic therapy of acute myocardial infarction with saruplase, a single-chain urokinase-type plasminogen activator (scu-PA) from recombinant bacteria
U Tebbe, WA Günzler, GR Hopkins, T Grymbowski, H Barth
Fibrinolysis and Proteolysis 1997
Decrease in urokinase-type plasminogen activator (u-PA) levels in patients with non-insulin dependent diabetes mellitus
K Krekora, E Vitacolonna, AD Castelnuovo, A D'Orazio, DD Lucia, G Dooijewaard, F Capani, MB Donati, L Iacoviello
Fibrinolysis and Proteolysis 1997
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker
1997
Thrombin Stimulation of Platelets Induces Plasminogen Activation Mediated by Endogenous Urokinase-Type Plasminogen Activator
C Lenich, JN Liu, V Gurewich
Blood 1997
Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism
U Nowak-Göttl, K Auberger, U Göbel, W Kreuz, R Schneppenheim, H Vielhaber, W Zenz, B Zieger
European Journal of Pediatrics 1996
REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING
V Tkachuk, V Stepanova, PJ Little, A Bobik
Clinical and Experimental Pharmacology and Physiology 1996
Transluminal Angioplasty, Thrombolysis, and Stenting for Extracranial and Intracranial Cerebral Vascular Disease
RT Higashida, FY Tsai, VV Halbach, CF Dowd, GB Hieshima
Journal of Interventional Cardiology 1996
Thrombolysis with prourokinase versus urokinase: An in vitro comparison
D Fox, K Ouriel, RM Green, J Stoughton, P Riggs, C Cimino
Journal of Vascular Surgery 1996
FIBRINOGEN AND FIBRIN-PROTEINS WITH COMPLEX ROLES IN HEMOSTASIS AND THROMBOSIS
B Blombäck
Thrombosis Research 1996
Preparation and Characterization of a Disulfide-Linked Bioconjugate of Annexin V with the B-Chain of Urokinase: An Improved Fibrinolytic Agent Targeted to Phospholipid-Containing Thrombi
K Tanaka, K Einaga, H Tsuchiyama, JF Tait, K Fujikawa
Biochemistry 1996
A Site-Directed Mutagenesis of Pro-urokinase Which Substantially Reduces Its Intrinsic Activity
JN Liu, W Tang, ZY Sun, W Kung, R Pannell, P Sarmientos, V Gurewich
Biochemistry 1996
Comparison of the pharmacokinetics and effects on the hemostatic system of saruplase and urokinase in patients with acute myocardial infarction
J Poeppelmeier, H Beier, J Carlsson, WA Guenzler, R Meierhenrich, GR Hopkins, U Tebbe
Journal of Thrombosis and Thrombolysis 1996
Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase*
JM van Griensven, KJ Burggraaf, J Gerloff, WA Günzler, H Beier, R Kroon, LG Huisman, RC Schoemaker, K Kluft, AF Cohen
Clinical Pharmacology & Therapeutics 1995
Centrifugal and roller pumps — are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?
BE Steinbrueckner, U Steigerwald, F Keller, K Neukam, O Elert, J Babin-Ebell
Heart and Vessels 1995
Sequential combination thrombolytic therapy for acute myocardial infarction: results of the pro-urokinase and t-PA enhancement of thrombolysis (PATENT) trial
SW Zarich, GJ Kowalchuk, WD Weaver, J Loscalzo, M Sassower, K Manzo, C Byrnes, JE Muller, V Gurewich
Journal of the American College of Cardiology 1995
Fibrinolytic Mechanism, Biochemistry, and Preclinical Pharmacology of Recombinant Prourokinase
RB Credo, SE Burke
Journal of Vascular and Interventional Radiology 1995
A combination of recombinant single-chain urokinase-type plasminogen activator and streptokinase has a synergistic non-fibrin specific action on in vitro clot lysis
GV Bashkov, JV Jitkova
Fibrinolysis 1995
Thrombolytic properties of pro-urokinase mutants with mutation in the epidermal growth factor-like domain
K Yano, H Morimoto, M Morita, T Tanabe
Fibrinolysis 1995
1 Mechanisms of physiological fibrinolysis
HR Lijnen, D Collen
Baillière's Clinical Haematology 1995
Fibrinolytic agents
F Bachmann
Fibrinolysis 1995
Pharmacokinetic and biochemical properties of human pro-urokinase variants carrying amino acids substitutions in the epidermal growth factor-like domain
M Morita, M Hirose, Y Amatsuji, S Hase, H Ishikawa, H Tamashima, E Asakura, M Ohkubo, T Tanabe
Fibrinolysis 1995
Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1
N Manchanda, BS Schwartz
The Journal of biological chemistry 1995
A double-blind multicenter comparison of the efficacy and safety ofsaruplase andurokinase in thetreatment ofacutemyocardialinfarction: Report of the SUTAMI study group
R Michels, H Hoffmann, J Windeler, H Barth, G Hopkins
Journal of Thrombosis and Thrombolysis 1995
Mechanisms of plasminogen activation
HR Lijnen, F Bachmann, D Collen, V Ellis, H Pannekoek, DC Rijken, S Thorsen
Journal of Internal Medicine 1994
Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C)
U NAULAND, DC RIJKEN
European Journal of Biochemistry 1994
Characterization of the Binding of Urokinase-type Plasminogen Activator (u-PA) to Plasminogen, to Plasminogen-activator Inhibitor-1 and to the u-PA Receptor
HR Lijnen, F Cock, D Collen
European Journal of Biochemistry 1994
Thrombolytic Agents
V Gurewich
New England Journal of Medicine 1994
Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces
E Anglés-Cano
Chemistry and Physics of Lipids 1994
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994
Practical Peripheral Arterial Thrombolysis
JJ Earnshaw
Practical Peripheral Arterial Thrombolysis 1994
Thrombolytic properties of an immunoconjugate between single-chain urokinase-type plasminogen activator (scu-PA) and F(ab′)2 of bispecific monoclonal antibody against fibrin and against u-PA in hamsters
T Kurokawa, A Watanabe, A Kakinuma, S Iwasa
Fibrinolysis 1994
Thrombolytic Therapy in Acute Stroke
RT Higashida, VV Halbach, SL Barnwell, CF Dowd, GB Hieshima
Journal of Endovascular Therapy 1994
Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase)
MS Stack, DA Johnson
The Journal of biological chemistry 1994
RP-HPLC peptide mapping methods for the analysis of recombinant human pro-urokinase
I Facchetti, A Valla, A Vigevani
Journal of Pharmaceutical and Biomedical Analysis 1993
Pro-urokinase and prekallikrein are both associated with platelets
V Gurewich, M Johnstone, JP Loza, R Pannell
FEBS Letters 1993
The role of urokinase generation during clot lysis by pro-urokinase in a plasma milieu
C Giorgetti, A Molinari, L Bonomini, J Lansen, V Gurewich
Fibrinolysis 1993
A study of the activation of fibrin-bound plasminogen by tissue-type plasminogen activator, single chain urokinase and sequential combinations of the activators
V Fleury, V Gurewich, E Anglés-Cano
Fibrinolysis 1993
New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia
MS Tallman, D Hakimian, HC Kwaan, FR Rickles
Leukemia & Lymphoma 1993
Thrombolytic Therapy: A Comprehensive Review of its Use in Clinical Medicine—Part I
WR Bell, MB Streiff
Journal of Intensive Care Medicine 1993
NMR studies of the dynamics of the multidomain protein urokinase-type plasminogen activator
UK Nowak, X Li, AJ Teuten, RA Smith, CM Dobson
Biochemistry 1993
Coronary rethrombosis after successful thrombolysis
V Gurewich
Circulation 1993
Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis
V Fleury, HR Lijnen, E Anglés-Cano
The Journal of biological chemistry 1993
Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala
HR LIJNEN, XK LI, L NELLES, MH HU, D COLLEN
European Journal of Biochemistry 1992
Multicenter dose-finding trial for thrombolysis with urokinase preactivated pro-urokinase (TCL 598) in acute myocardial infarction
DC Gulba, C Bode, S Sen, J Topp, K Fischer, H Wolf, H Hecker
Catheterization and Cardiovascular Diagnosis 1992
Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator
XK Li, HR Lijnen, L Nelles, MH Hu, D Collen
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1992
Pharmacokinetics and biochemical properties of human pro-urokinase variants carrying the deletion in epidermal growth factor-like domain
M Morita, M Hirose, Y Amatsuji, T Kawai, M Ohkubo, H Emoto, T Tanabe, H Kawabe, K Yokoyama
Fibrinolysis 1992
A comparison of the rates of clot lysis in a plasma milieu induced by tissue plasminogen activator (t-PA) and rec-pro-urokinase: Evidence that t-PA has a more restricted mode of action
R Pannell, V Gurewich
Fibrinolysis 1992
Differential detection of single chain urokinase-type plasminogen activator and two chain urokinase-type plasminogen activator in human and monkey plasma
A Molinari, C Giorgetti, L Bonomini, M Gerna, J Lansen, V Gurewich
Fibrinolysis 1992
Thrombolytic Therapy in Arterial Disease. I: Available Agents
WS Hillis, JD Gemmill, PD Macintyre, B Bhargava
1992
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells
AP Hansen, AM Petros, AP Mazar, TM Pederson, A Rueter, SW Fesik
Biochemistry 1992
Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK
J Liu, V Gurewich
Biochemistry 1992
A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase
JN Liu, R Pannell, V Gurewich
The Journal of biological chemistry 1992
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase
SA Rabbani, AP Mazar, SM Bernier, M Haq, I Bolivar, J Henkin, D Goltzman
The Journal of biological chemistry 1992
A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin
JN Liu, V Gurewich
Journal of Clinical Investigation 1991
Topically applied antithrombotic agents offer a new therapeutic approach to the prevention of microvascular thrombosis
BC Cooley, JS Gould
Microsurgery 1991
Importance of viability and attachment to an ascites tumor in the release of plasminogen activator
Q Dong, M Zhou, V Subbarao, C Ts'ao
The American Journal of Pathology 1991
Substrate specificity of tissue-type and urokinase-type plasminogen activators
DC Rijken, E Groeneveld
Biochemical and Biophysical Research Communications 1991
Efficient renaturation and fibrinolytic properties of prourokinase and a deletion mutant expressed in Escherichia coli as inclusion bodies
G ORSINI, A BRANDAZZA, P SARMIENTOS, A MOLINARI, J LANSEN, G CAUET
European Journal of Biochemistry 1991
Monoclonal Antibodies Monospecific to Single-Chain Urokinase-Type Plasminogen Activator (scu-PA)
JG Scheuerlein, I Kalies, WP Gluth, JR Kalden
Hybridoma 1991
The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation
C Lenich, R Pannell, V Gurewich
Thrombosis Research 1991
Taprostene, a stable prostacyclin analogue, enhances the thrombolytic efficacy of saruplase (recombinant single-chain urokinase-type plasminogen activator) in rabbits with pulmonary embolized thrombi
J Schneider
Prostaglandins 1991
Biotechnology of Blood
BJ Kudryk, A Bini, SF Rosebrough, TF Schaible
Biotechnology of Blood 1991
Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities
SS Husain
Biochemistry 1991
Thrombosis, fibrinolysis, and thrombolytic therapy: A perspective
S Sherry, VJ Marder
Progress in Cardiovascular Diseases 1991
Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
S Oshima, K Uchida, T Yasu, K Uno, H Nonogi, K Haze
Arteriosclerosis Thrombosis and Vascular Biology 1991
Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes
N Manchanda, BS Schwartz
The Journal of biological chemistry 1991
Cardiovascular Therapies in the 1990s: An Overview
RC Becker, JM Gore
Drugs 1991
Spin Filter Perfusion System for High Density Cell Culture: Production of Recombinant Urinary Type Plasminogen Activator in CHO Cells
GC Avgerinos, D Drapeau, JS Socolow, J Mao, K Hsiao, RJ Broeze
Bio/Technology 1990
Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: Evidence for synergism of low dose urokinase
W Kasper, SH Hohnloser, H Engler, T Meinertz, J Wilkens, E Roth, K Lang, P Limbourg, H Just
Journal of the American College of Cardiology 1990
Treatment of acute vascular occlusions with intra-arterial urokinase
DE Eisenbud, BJ Brener, R Shoenfeld, D Creighton, RJ Goldenkranz, DK Brief, J Alpert, J Huston, A Novick, UR Krishnan, V Parsonnet, J Nozick, P Cordero
The American Journal of Surgery 1990
Fibrinolytic properties of single chain urokinase-type plasminogen activator (Pro-urokinase)
GA Munk, DC Rijken
Fibrinolysis 1990
6 Mechanism of action of the thrombolytic agents
JI Weitz
Baillière's Clinical Haematology 1990
Construction, expression and biochemical characterisation of a novel triskringle plasminogen activator gene
NK Kalyan, J Wilhelm, SG Lee, SK Dheer, S Cheng, R Hjorth, WA Pierzchala, F Wiener, PP Hung
Fibrinolysis 1990
Tumour necrosis factor α stimulates the production of pro-urokinase from the A549 lung carcinoma cell line
AM Dosne, F Lutcher, R Beaupain, M Samama
Fibrinolysis 1990
Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model
D Collen, M Dewerchin, HJ Rapold, HR Lijnen, JM Stassen
Circulation 1990
Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator
C Bode, MS Runge, S Schönermark, T Eberle, JB Newell, W Kübler, E Haber
Circulation 1990
Pathophysiology and Rational Pharmacotherapy of Myocardial Ischemia
G Heusch
1990
Kinetics of producing pro-urokinase in perfusion cultivations
JK Kang, SK Ghoi, HY Lee
Biotechnology Letters 1990
Use of plasminogen activators in venous thrombosis
J Hirsh, AG Turpie
World Journal of Surgery 1990
Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis
CY Liu, S Chien
1990
Pathophysiologie und rationale Pharmakotherapie der Myokardischämie
G Heusch
1990
Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast
LM Melnick, BG Turner, P Puma, B Price-Tillotson, KA Salvato, DR Dumais, DT Moir, RJ Broeze, GC Avgerinos
The Journal of biological chemistry 1990
Thrombospondin forms complexes with single-chain and two-chain forms of urokinase
RL Silverstein, RL Nachman, R Pannell, V Gurewich, PC Harpel
The Journal of biological chemistry 1990
Inactivation of human tumor cell pro-urokinase by granulocyte elastase.
Kanayama N, Terao T
Japanese journal of cancer research : Gann 1990
Pharmacologic Control of Wound Healing in Glaucoma Filtration Surgery
MM Tahery, DA Lee
Journal of Ocular Pharmacology and Therapeutics 1989
Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin
M DEWERCHIN, HR LIJNEN, B HOEF, F COCK, D COLLEN
European Journal of Biochemistry 1989
The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase
V Gurewich
Fibrinolysis 1989
Activation of pro-urokinase by plasmin: Non-michaelian kinetics indicates a mechanism of negative cooperativity
MF Scully, V Ellis, Y Watahiki, VV Kakkar
Archives of Biochemistry and Biophysics 1989
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction
DC Gulba, K Fischer, M Barthels, U Polensky, GH Reil, WG Daniel, D Welzel, PR Lichtlen
The American Journal of Cardiology 1989
Potentiative effect of heparin in thrombolytic therapy of evolving myocardial infarction with natural pro-urokinase
DC Gulba, K Fischer, M Barthels, S Jost, W Möller, R Frombach, GH Reil, WG Daniel, PR Lichtlen
Fibrinolysis 1989
Production and characterisation of human recombinant single chain urokinase-type plasminogen activator from mouse cells
ML Nolli, E Sarubbi, A Corti, F Robbiati, A Soflientini, F Blasi, F Parenti, G Cassani
Fibrinolysis 1989
Thrombolytic properties of tissue plasminogen activator (t-PA) and single chain urokinase plasminogen activator (scu-PA) in vitro: Absence of synergy as demonstrated by two quantitative analytical methods
G Nguyen, J Fretault, M Samama, J Coursaget
Fibrinolysis 1989
Immunological properties of fibrin high affinity urokinase inhibitor complex in urine and plasma
S Hayashi, K Yamada
Fibrinolysis 1989
Influence of heparin and various glycosaminoglycans on activation of single chain urokinase-type plasminogen activator (scu-PA) by plasmin
Y Watahiki, MF Scully, V Ellis, VV Kakkar
Fibrinolysis 1989
Charge heterogeneity of recombinant pro-urokinase and urinary urokinase, as revealed by isoelectric focusing in immobilized pH gradients
PG Righetti, B Barzaghi, E Sarubbi, A Soffientini, G Cassani
Journal of Chromatography A 1989
Thrombolytic Therapy for Acute Myocardial Infarction
ER Bates, EJ Topol
Chest 1989
Circadian variation of plasma fibrinopeptide A level in patients with variant angina
H Ogawa, H Yasue, S Oshima, K Okumura, K Matsuyama, K Obata
Circulation 1989
Clot-selective coronary thrombolysis with pro-urokinase
J Loscalzo, TP Wharton, JM Kirshenbaum, HJ Levine, JT Flaherty, EJ Topol, K Ramaswamy, BD Kosowsky, DN Salem, P Ganz
Circulation 1989
Limitation of Infarct Size
H Schmutzler, W Rutsch, FC Dougherty
1989
Cancer Metastasis
V Schirrmacher, R Schwartz-Albiez
1989
Electrocardiography and Cardiac Drug Therapy
V Hombach, HH Hilger, HL Kennedy
1989
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
J Morganroth, EN Moore
1989
Newer agents for coronary thrombolysis. Perspectives from clinical studies
GD Minno, M Margaglione, AM Cerbone, R Papa, A Mattei
Pharmacological research : the official journal of the Italian Pharmacological Society 1989
Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina Pectoris:
J Loscalzo
Drugs 1989
Clinical disorders of fibrinolysis: A critical review
RB Francis
Blut Zeitschrift für die Gesamte Blutforschung 1989
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained
R Pannell, J Black, V Gurewich
Journal of Clinical Investigation 1988
Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158)
V Gurewich, R Pannell, RJ Broeze, J Mao
Journal of Clinical Investigation 1988
Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction
S Sherry
Journal of the American College of Cardiology 1988
COMPARISON OF THROMBOLYTIC, FIBRINOLYTIC, AND FIBRINOGENOLYTIC PROPERTIES OF TISSUE PLASMINOGEN ACTIVATOR, STREPTOKINASE, SINGLE-CHAIN UROKINASE, HIGH MOLECULAR WEIGHT AND LOW MOLECULAR WEIGHT UROKINASE IN HUMAN PLASMAIN VITRO
M Samama, G Nguyen, P Desnoyers, D Lourenco, J Fretault, M Horellou, J Conard, E Szwarcer, E Verdy, A Vahanian
Fundamental & Clinical Pharmacology 1988
A sequence-dependent monoclonal antibody specific for single-chain urokinase
JR Charpie, E Haber, GR Matsueda
Biochemical and Biophysical Research Communications 1988
Keratinocyte Urokinase-Type Plasminogen Activator is Secreted as a Single Chain Precursor
K Hashimoto, JH Prystowsky, J Baird, GS Lazarus, PJ Jensen
Journal of Investigative Dermatology 1988
Construction and expression of a hybrid plasminogen activator gene with sequences from non-protease region of tissue-type plasminogen activator (t-PA) and protease region of urokinase (u-PA)
NK Kalyan, SG Lee, SM Cheng, R Hartzell, C Urbano, PP Hung
Gene 1988
Isolation of a human cDNA of urokinase and its expression in COS-1 cells
SM Cheng, SG Lee, NK Kalyan, WT Hum, M Blume, R Vogel, PP Hung
Gene 1988
Fibrin-specific thrombolytic therapy
D Collen
Thrombosis Research 1988
Recombinant single-chain urokinase-type plasminogen activator (rscu-pa) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis
W Söhnge, JK Mickelson, PJ Simpson, BR Lucchesi
Thrombosis Research 1988
Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis
SF Badylak, S Voytik, RE Klabunde, J Henkin, M Leski
Thrombosis Research 1988
A rapid, simple method for monitoring fibrinolysis
SK Vernon
Thrombosis Research 1988
Production of an active urokinase by leukemia cells: A novel distinction from cell lines of solid tumors
R Stephens, R Alitalo, H Tapiovaara, A Vaheri
Leukemia Research 1988
Mechanisms of thrombus formation and lysis
DC Stump, KG Mann
Annals of Emergency Medicine 1988
Acute pulmonary embolism treated with thrombolytic agents: Current status of tPA and future implications for emergency medicine
CM Kessler, E Druy, SZ Goldhaber
Annals of Emergency Medicine 1988
Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction
C Bode, S Schoenermark, G Schuler, R Zimmermann, F Schwarz, W Kuebler
The American Journal of Cardiology 1988
The activation of human [Glu1]plasminogen by human single-chain urokinase
T Urano, VS de Serrano, PJ Gaffney, FJ Castellino
Archives of Biochemistry and Biophysics 1988
Effect of fibrinogen-clotting enzymes on secretion of plasminogen activators from cultured human endothelial cells
T Soszka, NE Kirschbaum, GJ Stewart, AZ Budzynski
Fibrinolysis 1988
Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators: Demonstration of a promoting effect by t-PA and by platelets on urokinase
V Gurewich, F Emmons, R Pannell
Fibrinolysis 1988
Reperfusion therapy of acute myocardial infarction
WW O'Neill, EJ Topol, B Pitt
Progress in Cardiovascular Diseases 1988
On future directions for cardiology. The Paul D. White lecture
E Braunwald
Circulation 1988
Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction
H Kambara, C Kawai, N Kajiwara, H Niitani, S Sasayama, K Kanmatsuse, K Kodama, H Sato, M Nobuyoshi, M Nakashima
Circulation 1988
New model of cerebral thrombosis in dogs
M Hirschberg, B Hofferberth
Stroke; a journal of cerebral circulation 1988
Endothelial Cell Biology in Health and Disease
N Simionescu, M Simionescu
1988
Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells
FM Booyse, PH Lin, M Traylor, R Bruce
The Journal of biological chemistry 1988
Structure-function analysis with tissue-type plasminogen activator. Effect of deletion of NH2-terminal domains on its biochemical and biological properties
NK Kalyan, SG Lee, J Wilhelm, KP Fu, WT Hum, R Rappaport, RW Hartzell, C Urbano, PP Hung
The Journal of biological chemistry 1988
One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity
LC Petersen, LR Lund, LS Nielsen, K Danø, L Skriver
The Journal of biological chemistry 1988
The search for the ideal thrombolytic agent
M Verstraete
Journal of the American College of Cardiology 1987
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy
D Collen
Journal of Cellular Biochemistry 1987
Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator
JC KIRCHHEIMER, I RESCH, G CHRIST, J WOJTA, BR BINDER
European Journal of Biochemistry 1987
A Modified Human Tissue Plasminogen Activator with Extended Half–Life In Vivo
D Lau, G Kuzma, CM Wei, DJ Livingston, N Hsiung
Bio/Technology 1987
Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor
AC Webb, KL Collins, SE Snyder, SJ Alexander, LJ Rosenwasser, RL Eddy, TB Shows, PE Auron
Journal of Experimental Medicine 1987
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
F Blasi, JD Vassalli, K Danø
The Journal of Cell Biology 1987
Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator
V Gurewich
Journal of the American College of Cardiology 1987
Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator
HR LIJNEN, B HOEF, D COLLEN
European Journal of Biochemistry 1987
Activation with plasmin of two-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin
HR LIJNEN, B HOEF, D COLLEN
European Journal of Biochemistry 1987
Physiologic regulation and pathologic disorders of fibrinolysis
CW Francis, VJ Marder
Human Pathology 1987
Stimulation of the plasma fibrinolytic activity in rats by the prostacyclin analogue CG 4203
J Schneider
Thrombosis Research 1987
Historical overview of antithrombotic and thrombolytic therapy
GV Sharma
The American Journal of Medicine 1987
Thrombolytic effect of pro-urokinase in vitro
H Bando, K Okada, O Matsuo
Fibrinolysis 1987
The Pulmonary Circulation in Health and Disease
J Hughes
The Pulmonary Circulation in Health and Disease 1987
Review: Thrombolytic Therapy for Patients with Acute Myocardial Infarction
JT Willerson, M Winniforo, LM Buja
The American Journal of the Medical Sciences 1987
The Fibrinolytic System and Its Pharmacologic Activation for Thrombolysis
S Sherry
Cardiology Clinics 1987
Activation of the Fibrinolytic System
AK Robison, D Collen
Cardiology Clinics 1987
Coronary Thrombolysis with TissueType Plasminogen Activator
SR Bergmann, PA Ludbrook, BE Sobel
Cardiology Clinics 1987
Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158
L Nelles, HR Lijnen, D Collen, WE Holmes
The Journal of biological chemistry 1987
Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study
V Ellis, MF Scully, VV Kakkar
The Journal of biological chemistry 1987
Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex:
H Ferres
Drugs 1987
Analysis of Coagulation and Fibrinolysis after Intravenous Anisoylated Plasminogen Streptokinase Activator Complex or Heparin in Patients with Acute Myocardial Infarction: A Belgian Multicentre Study
J Renkin, CC Beys, E Lavenne-Pardonge, H Pintens, J.
Drugs 1987
Fibrinogen and fibrin: Biochemistry and pathophysiology
AZ Budzynski, JR Shainoff
Critical Reviews in Oncology/Hematology 1986
Pharmacology of thrombolytic drugs
M Verstraete, D Collen
Journal of the American College of Cardiology 1986
Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis
JM Heiple, L Ossowski
Journal of Experimental Medicine 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: Effect on regional blood flow, infarct size and hemostasis
W Flameng, J Vanhaecke, DC Stump, FV de Werf, W Holmes, WA Guenzler, L Flohe, D Collen
Journal of the American College of Cardiology 1986
Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator
HR Lijnen, BV Hoef, D Collen
Biochimica et Biophysica Acta (BBA) - General Subjects 1986
THROMBOLYSIS: AN EFFECTIVE THERAPY IN ACUTE CORONARY THROMBOSIS
HD White, RM Norris
Australian and New Zealand Journal of Medicine 1986
Release of both urokinase and tissue plasminogen activator from veins
A Kjaeldgaard, B Larsson, B Astedt
Thrombosis Research 1986
Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture
DC Rijken, DJ Binnema, P Los
Thrombosis Research 1986
Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction
PL Zwerner, JM Gore
Journal of Intensive Care Medicine 1986
Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli
ME Winkler, M Blaber
Biochemistry 1986
Thrombolytic effect of single-chain pro-urokinase in a rabbit jugular vein thrombosis model
O Matsuo, H Bando, K Okada, K Tanaka, M Tsukada, Y Iga, H Arimura
Thrombosis Research 1986
Synergism of thrombolytic agents in vivo
D Collen, JM Stassen, DC Stump, M Verstraete
Circulation 1986
Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction
FV de Werf, J Vanhaecke, H de Geest, M Verstraete, D Collen
Circulation 1986
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex
S Ikram, S Lewis, C Bucknall, I Sram, N Thomas, R Vincent, D Chamberlain
BMJ : British Medical Journal 1986
Facts and Hopes in Thrombolysis in Acute Myocardial Infarction
S Effert, R von Essen, PG Hugenholtz, R Uebis, M Verstraete
1986
8 Advances in Clinical Fibrinolysis
LW Hessel, C Kluft
Clinics in Haematology 1986
Activation of plasminogen by pro-urokinase. I. Mechanism
HR Lijnen, C Zamarron, M Blaber, ME Winkler, D Collen
The Journal of biological chemistry 1986
Activation of plasminogen by pro-urokinase. II. Kinetics
D Collen, C Zamarron, HR Lijnen, M Hoylaerts
The Journal of biological chemistry 1986
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures
DC Stump, HR Lijnen, D Collen
The Journal of biological chemistry 1986
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex
DC Stump, M Thienpont, D Collen
The Journal of biological chemistry 1986
Current Issues in Thrombosis Prevention with Antiplatelet Drugs:
G de Gaetano, C Cerletti, E Dejana, J Vermylen
Drugs 1986
Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins
N Toki, H Sumi, K Sasaki, I Boreisha, KC Robbins
Journal of Clinical Investigation 1985
Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase
U Delvos, G Müller-Berghaus
Klinische Wochenschrift 1985
Characterization of the high-affinity interaction between human plasminogen and pro-urokinase
HR LIJNEN, C ZAMARRON, D COLLEN
European Journal of Biochemistry 1985
Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli
WE Holmes, D Pennica, M Blaber, MW Rey, WA Guenzler, GJ Steffens, HL Heyneker
Bio/Technology 1985
Fibrinogenolysis and fibrinolysis in normal volunteers and patients with thrombosis after infusion of urokinase
T Urano, T Kamiya, S Sakaguchi, Y Takada, A Takada
Thrombosis Research 1985
Antithrombotic therapy in coronary artery disease
V Bertelé, EW Salzman
Arteriosclerosis (Dallas, Tex.) 1985
Coronary thrombolysis in dogs with intravenously administered human pro-urokinase
D Collen, D Stump, F van de Werf, IK Jang, M Nobuhara, HR Lijnen
Circulation 1985
Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase
RL Rothbard, PG Fitzpatrick, CW Francis, DM Caton, WB Hood, VJ Marder
Circulation 1985
Acute Coronary Care 1986
RM Califf, GS Wagner
1985
Improvement of Myocardial Perfusion
J Meyer, R Erbel, HJ Rupprecht
1985
The Fibrinolytic System of the Vascular Wall
LA Erickson, RR Schleef, T Ny, DJ Loskutoff
Clinics in Haematology 1985
The fibrinolytic system in man
AP Reiner, WR Bell
Critical Reviews in Oncology/Hematology 1984
Kidney Plasminogen Activator: A Precursor Form of Human Urokinase With High Fibrin Affinity
T Kohno, P Hopper, JS Lillquist, RL Suddith, R Greenlee, DT Moir
Bio/Technology 1984
New approaches to thrombolytic therapy
D Collen, HR Lijnen
Arteriosclerosis (Dallas, Tex.) 1984
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983
Protides of the Biological Fluids
PA Small, RH Waldman
Protides of the Biological Fluids 1969
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel
1962
Clinical Chemistry
RM Archibald
Analytical Chemistry 1953

← Previous 1 2 3 … 9 10 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
33 readers on Mendeley
See more details